Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy T2 Biosystms stock

Learn how to easily invest in T2 Biosystms stock.

T2 Biosystms Inc is a diagnostics & research business based in the US. T2 Biosystms shares (TTOO) are listed on the NASDAQ and all prices are listed in US Dollars. T2 Biosystms employs 182 staff and has a trailing 12-month revenue of around $27.6 million.

How to buy shares in T2 Biosystms

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TTOO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

T2 Biosystms stock price (NASDAQ: TTOO)

Use our graph to track the performance of TTOO stocks over time.

T2 Biosystms shares at a glance

Information last updated 2022-09-25.
Latest market close$0.11
52-week range$0.09 - $1.08
50-day moving average $0.13
200-day moving average $0.31
Wall St. target price$0.20
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.34

Buy T2 Biosystms shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy T2 Biosystms stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

T2 Biosystms price performance over time

Historical closes compared with the close of $0.113 from 2022-09-30

1 week (2022-09-23) 6.60%
1 month (2022-09-01) -3.42%
3 months (2022-07-01) -33.53%
6 months (2022-03-28) N/A
1 year (2021-10-01) -87.95%
2 years (2020-10-01) -91.37%
3 years (2019-10-01) 2.39
5 years (2017-09-29) 4.2

T2 Biosystms financials

Revenue TTM $27.6 million
Gross profit TTM $-14,446,000
Return on assets TTM -55.24%
Return on equity TTM -622.14%
Profit margin -220.07%
Book value $0.05
Market capitalisation $37.4 million

TTM: trailing 12 months

T2 Biosystms share dividends

We're not expecting T2 Biosystms to pay a dividend over the next 12 months.

T2 Biosystms share price volatility

Over the last 12 months, T2 Biosystms's shares have ranged in value from as little as $0.089 up to $1.08. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while T2 Biosystms's is 0.4814. This would suggest that T2 Biosystms's shares are less volatile than average (for this exchange).

T2 Biosystms overview

T2 Biosystems, Inc. , an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U. S.

Frequently asked questions

What percentage of T2 Biosystms is owned by insiders or institutions?
Currently 2.374% of T2 Biosystms shares are held by insiders and 5.525% by institutions.
How many people work for T2 Biosystms?
Latest data suggests 182 work at T2 Biosystms.
When does the fiscal year end for T2 Biosystms?
T2 Biosystms's fiscal year ends in December.
Where is T2 Biosystms based?
T2 Biosystms's address is: 101 Hartwell Avenue, Lexington, MA, United States, 02421
What is T2 Biosystms's ISIN number?
T2 Biosystms's international securities identification number is: US89853L1044
What is T2 Biosystms's CUSIP number?
T2 Biosystms's Committee on Uniform Securities Identification Procedures number is: 89853L104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site